drugset / Trial / NCT02382068
Dexamethasone in Preventing Hearing Loss in Patients Receiving Cisplatin
Withdrawn
Aaron Moberly
NaSingle-groupOpen-labelSupportive care
Summary
This randomized pilot clinical trial studies dexamethasone in preventing hearing loss in patients receiving cisplatin. Injecting a steroid, such as dexamethasone, behind the eardrum before chemotherapy may help protect against cisplatin-associated hearing loss.
Timeline
- Start
- 2014-08
- Primary completion
- 2017-07
- Completion
- 2017-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | — | Intrathecal |
| Background | Cisplatin | Other / unclassified | 50 mg/m2 | — |